LncRNA SLC2A1-AS1 affects aerobic glycolysis and progression by inhibiting STAT3/FOXM1/GLUT1 signaling pathway in hepatocellular carcinoma [48]. This evidence concerns the gene SLC2A1 and hepatocellular carcinoma.